Company / Capital Expenditures
Evolent Health, Inc. Capital Expenditures History
FY2016-FY2019 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Capital Expenditures
$35.5M
FY2019
5-year range
-
FY2016-FY2019
Trend
-10.2%
vs FY2018
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from $28M to $36M over the past 2 years.
Based on SEC 10-K filings.
$36M in FY2019 with a 3-year CAGR of +31.8%.
Improved from $28M to $36M over the past 2 years.
Capital Expenditures over time
Growth rates
- 3-Year CAGR
- +31.8%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- 3-year CAGR of +31.8%, indicating consistent growth.
- In FY2019, capital expenditures decreased 10.2% year-over-year.
Company context
Key Data Points
- Altman Z-Score -0.84 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Capital ExpendituresValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | - | - |
| FY2022 | - | - |
| FY2021 | - | - |
| FY2020 | - | - |
| FY2019 | $35.5M | -10.2% |
| FY2018 | $39.5M | +42.0% |
| FY2017 | $27.8M | +79.4% |
| FY2016 | $15.5M | +138.3% |
As of FY2019 · SEC Form 10-K · Last checked Jun 21, 2026